Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia
Autor: | Kostapanos, Michael S., Milionis, Haralampos J., Lagos, Konstantinos G., Rizos, Christos B., Tselepis, Alexandros D., Elisaf, Moses S. |
---|---|
Zdroj: | In European Journal of Pharmacology 2008 590(1):327-332 |
Databáze: | ScienceDirect |
Externí odkaz: |